Local overexpression of the myostatin propeptide increases glucose transporter expression and enhances skeletal muscle glucose disposal
Open accessThe DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Abstract
Insulin resistance (IR) in skeletal muscle is a prerequisite for type 2 diabetes and is often associated with obesity. IR also develops alongside muscle atrophy in older individuals in sarcopenic obesity. The molecular defects that underpin this syndrome are not well characterized, and there is no licensed treatment. Deletion of the transforming growth factor-β family member myostatin, or sequestration of the active peptide by overexpression of the myostatin propeptide/latency-associated peptide (ProMyo) results in both muscle hypertrophy and reduced obesity and IR. We aimed to establish whether local myostatin inhibition would have a paracrine/autocrine effect to enhance glucose disposal beyond that simply generated by increased muscle mass, and the mechanisms involved. We directly injected adeno-associated virus expressing ProMyo in right tibialis cranialis/extensor digitorum longus muscles of rats and saline in left muscles and compared the effects after 17 days. Both test muscles were increased in size (by 7 and 11%) and showed increased radiolabeled 2-deoxyglucose uptake (26 and 47%) and glycogen storage (28 and 41%) per unit mass during an intraperitoneal glucose tolerance test. This was likely mediated through increased membrane protein levels of GLUT1 (19% higher) and GLUT4 (63% higher). Interestingly, phosphorylation of phosphoinositol 3-kinase signaling intermediates and AMP-activated kinase was slightly decreased, possibly because of reduced expression of insulin-like growth factor-I in these muscles. Thus, myostatin inhibition has direct effects to enhance glucose disposal in muscle beyond that expected of hypertrophy alone, and this approach may offer potential for the therapy of IR syndromes.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Stitt, T. N., Drujan, D., Clarke, B. A., Panaro, F., Timofeyva, Y., Kline, W. O., Gonzalez, M., Yancopoulos, G. D., & Glass, D. J. (2004) · Molecular Cell · doi:10.1016/s1097-2765(04)00211-4 · Cited by 1,964
Regulation of myostatin activity and muscle growth
Lee, S.-J., & McPherron, A. C. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.151270098 · Cited by 1,616
Rommel, C., Bodine, S. C., Clarke, B. A., Rossman, R., Nunez, L., Stitt, T. N., Yancopoulos, G. D., & Glass, D. J. (2001) · Nature Cell Biology · doi:10.1038/ncb1101-1009 · Cited by 1,583
Sandri, M., Lin, J., Handschin, C., Yang, W., Arany, Z. P., Lecker, S. H., Goldberg, A. L., & Spiegelman, B. M. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0607795103 · Cited by 974
Sarcopenia: characteristics, mechanisms and functional significance
Narici, M. V., & Maffulli, N. (2010) · British Medical Bulletin · doi:10.1093/bmb/ldq008 · Cited by 827
Myostatin reduces Akt/TORC1/p70S6K signaling, inhibiting myoblast differentiation and myotube size
Trendelenburg, A. U., Meyer, A., Rohner, D., Boyle, J., Hatakeyama, S., & Glass, D. J. (2009) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00105.2009 · Cited by 792
Suppression of body fat accumulation in myostatin-deficient mice
McPherron, A. C., & Lee, S.-J. (2002) · Journal of Clinical Investigation · doi:10.1172/jci0213562 · Cited by 505
Guo, T., Jou, W., Chanturiya, T., Portas, J., Gavrilova, O., & McPherron, A. C. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004937 · Cited by 402 · cited 1×
“As might be predicted, therefore, myostatin null and mutant mice also resist diet-induced obesity and IR (17, 34, 54, 59), while conversely administration of myostatin to mice causes IR (19).”
Bruss, M. D., Arias, E. B., Lienhard, G. E., & Cartee, G. D. (2005) · Diabetes · doi:10.2337/diabetes.54.1.41 · Cited by 273 · cited 2×
“Translocation of GLUT4 to the plasma membrane from its intracellular depot is required for insulin-stimulated glucose uptake by muscle cells, involving inhibition of the GTPase activity of the RabGTPase-activating protein Akt substrate of 160 kDa (AS160/ TBC1D4) (7), whereas GSK3 -mediated disinhibition of glycogen sy…”
Myostatin decreases with aerobic exercise and associates with insulin resistance
HITTEL, D. S., AXELSON, M., SARNA, N., SHEARER, J., HUFFMAN, K. M., & KRAUS, W. E. (2010) · Medicine & Science in Sports & Exercise · doi:10.1249/mss.0b013e3181e0b9a8 · Cited by 271 · cited 1×
“As might be predicted, therefore, myostatin null and mutant mice also resist diet-induced obesity and IR (17, 34, 54, 59), while conversely administration of myostatin to mice causes IR (19).”
Zhang, C., McFarlane, C., Lokireddy, S., Masuda, S., Ge, X., Gluckman, P. D., Sharma, M., & Kambadur, R. (2012) · Diabetologia · doi:10.1007/s00125-011-2304-4 · Cited by 192 · cited 3×
“As might be predicted, therefore, myostatin null and mutant mice also resist diet-induced obesity and IR (17, 34, 54, 59), while conversely administration of myostatin to mice causes IR (19).”
Transgenic expression of myostatin propeptide prevents diet-induced obesity and insulin resistance
Zhao, B., Wall, R. J., & Yang, J. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2005.09.044 · Cited by 186
Sonntag, F., Köther, K., Schmidt, K., Weghofer, M., Raupp, C., Nieto, K., Kuck, A., Gerlach, B., Böttcher, B., Müller, O. J., et al. (2011) · Journal of Virology · doi:10.1128/jvi.05359-11 · Cited by 184
Allen, D. L., Cleary, A. S., Speaker, K. J., Lindsay, S. F., Uyenishi, J., Reed, J. M., Madden, M. C., & Mehan, R. S. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00798.2007 · Cited by 183 · cited 1×
“In addition, myostatin mRNA is increased in muscle from ob/ob and high-fat diet-fed mice (2) and obese (35, 40) and diabetic (39) humans, but, significantly, this change is not reflected in altered plasma levels in the latter group (6).”
Zhang, C., McFarlane, C., Lokireddy, S., Bonala, S., Ge, X., Masuda, S., Gluckman, P. D., Sharma, M., & Kambadur, R. (2011) · Diabetologia · doi:10.1007/s00125-011-2079-7 · Cited by 158
The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity
Akpan, I., Goncalves, M. D., Dhir, R., Yin, X., Pistilli, E. E., Bogdanovich, S., Khurana, T. S., Ucran, J., Lachey, J., & Ahima, R. S. (2009) · International Journal of Obesity · doi:10.1038/ijo.2009.162 · Cited by 140 · cited 1×
“A number of approaches aimed at reducing myostatin action for the treatment of muscular dystrophies have already been considered, including gene therapy by delivery of myostatin-inhibiting genes, propeptide or small-interfering RNA using AAV or retrovirus (12, 18, 57), administration of antimyostatin blocking antibodi…”
Akt deficiency attenuates muscle size and function but not the response to ActRIIB inhibition
Goncalves, M. D., Pistilli, E. E., Balduzzi, A., Birnbaum, M. J., Lachey, J., Khurana, T. S., & Ahima, R. S. (2010) · PLoS ONE · doi:10.1371/journal.pone.0012707 · Cited by 69 · cited 2×
“The results of transgenic overexpression of GLUT4 in muscle (51) suggest that this change would be sufficient to explain the improved glucose disposal observed here, and indeed both basal and insulin-stimulated glucose disposal and GLUT4 protein were elevated in an analogous in vivo model of deficient myostatin action…”
Research works printed but not linked: 43
- 10.1210/en.2008-0959 · DOI · Paper page
- 10.1074/jbc.M706678200 · DOI · Paper page
- 10.1126/science.1065874 · DOI · Paper page
- 10.1371/journal.pone.0037236 · DOI · Paper page
- 10.1038/aps.2010.73 · DOI
- 10.1126/science.292.5522.1728 · DOI · Paper page
- 10.2337/diabetes.53.12.3258 · DOI · Paper page
- 10.1210/me.2006-0154 · DOI · Paper page
- 10.1089/rej.2008.0815 · DOI
- 10.1210/en.2006-0539 · DOI · Paper page
- 10.1074/jbc.M705325200 · DOI · Paper page
- 10.2337/db11-0915 · DOI · Paper page
- 10.1073/pnas.0709144105 · DOI · Paper page
- 10.1007/s00125-011-2205-6 · DOI · Paper page
- 10.1074/jbc.M400674200 · DOI · Paper page
- 10.1038/mt.2010.212 · DOI
- 10.1016/S1474-4422(09)70211-X · DOI · Paper page
- 10.1152/japplphysiol.01091.2007 · DOI · Paper page
- 10.1074/jbc.M204291200 · DOI · Paper page
- 10.1096/fj.10-155994 · DOI · Paper page
- 10.2174/187152210793663748 · DOI · Paper page
- 10.1172/JCI29044 · DOI · Paper page
- 10.1002/jgm.946 · DOI · Paper page
- 10.1016/j.yexcr.2008.01.004 · DOI
- 10.1016/j.nmd.2009.06.367 · DOI
- 10.1038/387083a0 · DOI · Paper page
- 10.1210/jc.2003-032047 · DOI · Paper page
- 10.1016/j.expneurol.2009.02.017 · DOI
- 10.1210/en.2011-0155 · DOI · Paper page
- 10.1371/journal.pone.0006575 · DOI · Paper page
- 10.1152/physiolgenomics.00045.2006 · DOI · Paper page
- 10.1210/en.2012-1368 · DOI · Paper page
- Philippou A, 2007, J Musculoskelet Neuronal Interact, 7, 208
- 10.1152/ajpendo.00537.2007 · DOI
- 10.1097/MCO.0b013e328312c37d · DOI · Paper page
- 10.1038/377173a0 · DOI · Paper page
- 10.2337/diab.45.1.28 · DOI · Paper page
- 10.1002/ana.21338 · DOI · Paper page
- 10.1016/S1043-2760(02)00662-8 · DOI · Paper page
- 10.2337/db08-0245 · DOI · Paper page
- 10.1210/en.2010-0488 · DOI
- 10.1074/jbc.M610185200 · DOI · Paper page
- 10.1002/jgm.1216 · DOI
Cited by
Insulin resistance and sarcopenia: mechanistic links between common co-morbidities
Cleasby, M. E., Jamieson, P. M., & Atherton, P. J. (2016) · Journal of Endocrinology · doi:10.1530/joe-15-0533 · Cited by 596
Self-citationMyokines and Adipokines: Involvement in the Crosstalk between Skeletal Muscle and Adipose Tissue
Li, F., Li, Y., Duan, Y., Hu, C.-A. A., Tang, Y., & Yin, Y. (2017) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2016.10.003 · Cited by 288
Mechanism of increased risk of insulin resistance in aging skeletal muscle
Shou, J., Chen, P.-J., & Xiao, W.-H. (2020) · Diabetology & Metabolic Syndrome · doi:10.1186/s13098-020-0523-x · Cited by 283
Stefanakis, K., Kokkorakis, M., & Mantzoros, C. S. (2024) · Metabolism · doi:10.1016/j.metabol.2024.156057 · Cited by 142
Myokines as possible therapeutic targets in cancer cachexia
Manole, E., Ceafalan, L. C., Popescu, B. O., Dumitru, C., & Bastian, A. E. (2018) · Journal of Immunology Research · doi:10.1155/2018/8260742 · Cited by 60
Metadata
- Authors
- Cleasby, M. E., Jarmin, S., Eilers, W., Elashry, M., Andersen, D. K., Dickson, G., & Foster, K.
- Venue
- American Journal of Physiology-Endocrinology and Metabolism
- Publisher
- American Physiological Society
- Published
- 2014-04-01
- Volume
- 306
- Issue
- 7
- Pages
- E814-E823
- ISSN
- 0193-1849 (ISSN-L)
- 1522-1555
- OpenAlex
- W2165894289
- Cited by
- 55
- References
- 17
- FWCI
- 2.31
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.